Business Description
Cannasouth Ltd
ISIN : NZCBDE0009S6
Share Class Description:
NZSE:CBD: Ordinary SharesCompare
Compare
Traded in other countries / regions
CBD.New Zealand IPO Date
2019-06-19Description
Cannasouth Ltd is a New Zealand based company involved in the medicinal cannabis sector. Its focus is to research the benefits of medicinal cannabis and to develop a range of medicinal cannabis-related products for distribution in New Zealand and globally. The company operates in single segment: the biopharmaceutics market i.e., the production and supply (including research and development) of biopharmaceuticals, specializing in cannabinoid medicines; with the area of operation being New Zealand.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.47 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.57 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.68 | |||||
| Beneish M-Score | 49.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 58.7 | |||||
| 3-Year EBITDA Growth Rate | -8 | |||||
| 3-Year EPS without NRI Growth Rate | -6.5 | |||||
| 3-Year FCF Growth Rate | -14 | |||||
| 3-Year Book Growth Rate | 9.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.72 | |||||
| 9-Day RSI | 25.53 | |||||
| 14-Day RSI | 29.79 | |||||
| 6-1 Month Momentum % | -41.2 | |||||
| 12-1 Month Momentum % | -65.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.85 | |||||
| Quick Ratio | 1.06 | |||||
| Cash Ratio | 0.83 | |||||
| Days Inventory | 210.16 | |||||
| Days Sales Outstanding | 107.53 | |||||
| Days Payable | 293.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.4 | |||||
| Shareholder Yield % | -18.59 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -127.75 | |||||
| Operating Margin % | -910.89 | |||||
| Net Margin % | -922.83 | |||||
| FCF Margin % | -991.2 | |||||
| ROE % | -23.43 | |||||
| ROA % | -20.05 | |||||
| ROIC % | -22.12 | |||||
| ROC (Joel Greenblatt) % | -72.12 | |||||
| ROCE % | -21.09 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 32.67 | |||||
| PB Ratio | 0.67 | |||||
| Price-to-Tangible-Book | 1.23 | |||||
| EV-to-EBIT | -4.07 | |||||
| EV-to-EBITDA | -4.07 | |||||
| EV-to-Revenue | 36.64 | |||||
| EV-to-FCF | -3.7 | |||||
| Earnings Yield (Greenblatt) % | -24.57 | |||||
| FCF Yield % | -29.23 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers